BioCentury
ARTICLE | Company News

AOP Orphan sales and marketing update

November 17, 2014 8:00 AM UTC

AOP Orphan launched Thromboreductin anagrelide in Russia to treat essential thrombocythemia. The product comes in 0.5 mg capsules. ...